These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12164804)

  • 1. Plasmapheresis in thrombotic microangiopathy-associated syndromes: review of outcome data derived from clinical trials and open studies.
    von Baeyer H
    Ther Apher; 2002 Aug; 6(4):320-8. PubMed ID: 12164804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials.
    Michael M; Elliott EJ; Craig JC; Ridley G; Hodson EM
    Am J Kidney Dis; 2009 Feb; 53(2):259-72. PubMed ID: 18950913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review.
    Bosch T; Wendler T
    Ther Apher; 2001 Jun; 5(3):182-5. PubMed ID: 11467754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical management of hemolytic-uremic syndrome and thrombotic-thrombocytopenic purpura].
    Keller F; Schwarze H; Schwarz A
    Wien Klin Wochenschr; 1994; 106(19):603-7. PubMed ID: 7998406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura.
    Michael M; Elliott EJ; Ridley GF; Hodson EM; Craig JC
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD003595. PubMed ID: 19160220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
    Clark WF
    Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmapheresis for thrombotic thrombocytopenic purpura following bone marrow transplantation.
    Kolker O; Sviri S; Linton DM; Or R; Nagler A; Shapira MY
    Acta Haematol; 2001; 105(3):156-8. PubMed ID: 11463989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renal manifestations and outcome of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in adults.
    Conlon PJ; Howell DN; Macik G; Kovalik EC; Smith SR
    Nephrol Dial Transplant; 1995; 10(7):1189-93. PubMed ID: 7478122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic plasmapheresis for the treatment of the thrombotic thrombocytopenic purpura-haemolytic uraemic syndromes.
    Hwang WY; Chai LY; Ng HJ; Goh YT; Tan PH
    Singapore Med J; 2004 May; 45(5):219-23. PubMed ID: 15143357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombotic microangiopathy: when time is the key factor!].
    Hemett OM; Martins F; Descombes E; Betticher D; Hayoz D
    Rev Med Suisse; 2014 Apr; 10(425):794, 796-803. PubMed ID: 24791425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporin.
    Boctor FN
    Egypt J Immunol; 2006; 13(2):95-9. PubMed ID: 18689275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P; Remuzzi G
    J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal treatment of thrombotic microangiopathy: a ten year experience.
    Bueno D; Sevigny J; Kaplan AA
    Ther Apher; 1999 Nov; 3(4):294-7. PubMed ID: 10608720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP) complicating adult Still's disease: remission induced with intravenous immunoglobulin G.
    Diamond JR
    J Nephrol; 1997; 10(5):253-7. PubMed ID: 9364316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of thrombotic microangiopathies].
    Debourdeau P; Zammit C; Souleau B; Védrine L; Farge-Bancel D
    Ann Med Interne (Paris); 1999 Sep; 150(5):374-87. PubMed ID: 10544747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Wada H; Matsumoto T; Yamashita Y
    Semin Thromb Hemost; 2014 Nov; 40(8):866-73. PubMed ID: 25377323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and treatment of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS).
    Kakishita E
    Int J Hematol; 2000 Jun; 71(4):320-7. PubMed ID: 10905050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombotic microangiopathy : Relevant new aspects for intensive care physicians].
    Gaggl M; Aigner C; Sunder-Plassmann G; Schmidt A
    Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):434-9. PubMed ID: 27255224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.
    Coppo P; Bussel A; Charrier S; Adrie C; Galicier L; Boulanger E; Veyradier A; Leblanc T; Alberti C; Azoulay E; Le Gall JR; Schlemmer B
    Medicine (Baltimore); 2003 Jan; 82(1):27-38. PubMed ID: 12544708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.